EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients

Zeeba Saeed iD, Vittorio Sirolli, Mario Bonomini iD, Sabina Gallina iD, Giulia Renda iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25168705 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Zeeba Saeed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Studies and Technology, G. d'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Thrombosis, Hemorrhage. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is a global health issue causing a significant health burden. CKD patients develop thrombotic and hemorrhagic complications, and cardiovascular diseases are associated with increased hospitalization and mortality in this population. The hemostatic alterations are multifactorial in these patients; therefore, the results of different studies are varying and controversial. Endothelial and platelet dysfunction, coagulation abnormalities, comorbidities, and hemoincompatibility of the dialysis membranes are major contributors of hypo- and hypercoagulability in CKD patients. Due to the tendency of CKD patients to exhibit a prothrombotic state and bleeding risk, they require personalized clinical assessment to understand the impact of antithrombotic therapy. The evidence of efficacy and safety of antiplatelet and anticoagulant treatments is limited for end-stage renal disease patients due to their exclusion from major randomized clinical trials. Moreover, designing hemocompatible dialyzer membranes could be a suitable approach to reduce platelet activation, coagulopathy, and thrombus formation. This review discusses the molecular mechanisms underlying thrombotic and hemorrhagic risk in patients with CKD, leading to cardiovascular complications in these patients, as well as the evidence and guidance for promising approaches to optimal therapeutic management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicThrombosisHemorrhageHumansRisk FactorsAnticoagulantsBlood CoagulationAnimals

Stichwörter der Autor:innen

anticoagulantsantiplateletschronic kidney diseasehemodialysis membraneshemostatic dysfunction

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Center for Advanced Studies and Technology, G. d'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy.
  • Nephrology and Dialysis Unit, Department of Medicine, G. d'Annunzio University of Chieti-Pescara, SS. Annunziata Hospital, Via dei Vestini, 66100 Chieti, Italy.
  • Department of Neuroscience, Imaging and Clinical Sciences, G. d'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy.

ORCID-Profile: Zeeba Saeed, Mario Bonomini, Sabina Gallina, Giulia Renda

Zitieren

APA

Saeed, Z., Sirolli, V., Bonomini, M., Gallina, S., & Renda, G. (2024). Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168705

Vancouver

Saeed Z, Sirolli V, Bonomini M, Gallina S, Renda G. Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168705

BibTeX
@article{Saeed2024,
  author = {Saeed, Zeeba and Sirolli, Vittorio and Bonomini, Mario and Gallina, Sabina and Renda, Giulia},
  title = {Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25168705}
}
Kostenlos starten →